CDK4/6 inhibitors in the treatment of metastatic breast cancer

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Ettl, Johannes (VerfasserIn) , Marmé, Frederik (VerfasserIn)
Dokumenttyp: Article (Journal) Editorial
Sprache:Englisch
Veröffentlicht: April 26, 2017
In: Breast care
Year: 2017, Jahrgang: 12, Heft: 2, Pages: 118-120
ISSN:1661-3805
DOI:10.1159/000475541
Online-Zugang:Verlag, Pay-per-use, Volltext: http://dx.doi.org/10.1159/000475541
Verlag, Pay-per-use, Volltext: https://www.karger.com/Article/FullText/475541
Volltext
Verfasserangaben:Chair: Johannes Ettl, Paricipants: Jens Huober, Diana Lüftner, Frederik Marmé, Rachel Würstlein

MARC

LEADER 00000caa a2200000 c 4500
001 1584434473
003 DE-627
005 20220815064730.0
007 cr uuu---uuuuu
008 181126s2017 xx |||||o 00| ||eng c
024 7 |a 10.1159/000475541  |2 doi 
035 |a (DE-627)1584434473 
035 |a (DE-576)514434473 
035 |a (DE-599)BSZ514434473 
035 |a (OCoLC)1341024078 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Ettl, Johannes  |d 1969-  |e VerfasserIn  |0 (DE-588)12179282X  |0 (DE-627)08153793X  |0 (DE-576)182048861  |4 aut 
245 1 0 |a CDK4/6 inhibitors in the treatment of metastatic breast cancer  |c Chair: Johannes Ettl, Paricipants: Jens Huober, Diana Lüftner, Frederik Marmé, Rachel Würstlein 
264 1 |c April 26, 2017 
300 |a 3 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 26.11.2018 
700 1 |a Marmé, Frederik  |d 1974-  |e VerfasserIn  |0 (DE-588)132561972  |0 (DE-627)52394893X  |0 (DE-576)299226549  |4 aut 
773 0 8 |i Enthalten in  |t Breast care  |d Basel : Karger, 2006  |g 12(2017), 2, Seite 118-120  |h Online-Ressource  |w (DE-627)501078142  |w (DE-600)2205941-6  |w (DE-576)276272617  |x 1661-3805  |7 nnas  |a CDK4/6 inhibitors in the treatment of metastatic breast cancer 
773 1 8 |g volume:12  |g year:2017  |g number:2  |g pages:118-120  |g extent:3  |a CDK4/6 inhibitors in the treatment of metastatic breast cancer 
856 4 0 |u http://dx.doi.org/10.1159/000475541  |x Verlag  |x Resolving-System  |z Pay-per-use  |3 Volltext 
856 4 0 |u https://www.karger.com/Article/FullText/475541  |x Verlag  |z Pay-per-use  |3 Volltext 
951 |a AR 
992 |a 20181126 
993 |a Editorial 
994 |a 2017 
998 |g 132561972  |a Marmé, Frederik  |m 132561972:Marmé, Frederik  |d 910000  |d 910400  |e 910000PM132561972  |e 910400PM132561972  |k 0/910000/  |k 1/910000/910400/  |p 4 
999 |a KXP-PPN1584434473  |e 3034053541 
BIB |a Y 
SER |a journal 
JSO |a {"person":[{"role":"aut","given":"Johannes","family":"Ettl","display":"Ettl, Johannes"},{"role":"aut","family":"Marmé","given":"Frederik","display":"Marmé, Frederik"}],"title":[{"title":"CDK4/6 inhibitors in the treatment of metastatic breast cancer","title_sort":"CDK4/6 inhibitors in the treatment of metastatic breast cancer"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"origin":[{"dateIssuedKey":"2017","dateIssuedDisp":"April 26, 2017"}],"note":["Gesehen am 26.11.2018"],"recId":"1584434473","id":{"eki":["1584434473"],"doi":["10.1159/000475541"]},"relHost":[{"recId":"501078142","id":{"eki":["501078142"],"issn":["1661-3805"],"zdb":["2205941-6"]},"part":{"volume":"12","pages":"118-120","extent":"3","year":"2017","issue":"2","text":"12(2017), 2, Seite 118-120"},"physDesc":[{"extent":"Online-Ressource"}],"disp":"CDK4/6 inhibitors in the treatment of metastatic breast cancerBreast care","language":["eng"],"pubHistory":["1.2006 -"],"title":[{"title":"Breast care","subtitle":"multidisciplinary journal for research, diagnosis and therapy","title_sort":"Breast care"}],"origin":[{"dateIssuedDisp":"2006-","publisher":"Karger","publisherPlace":"Basel","dateIssuedKey":"2006"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"note":["Gesehen am 04.04.2019"]}],"name":{"displayForm":["Chair: Johannes Ettl, Paricipants: Jens Huober, Diana Lüftner, Frederik Marmé, Rachel Würstlein"]},"physDesc":[{"extent":"3 S."}],"language":["eng"]} 
SRT |a ETTLJOHANNCDK46INHIB2620